Anteris Technologies Global Corp.
NASDAQ:AVRMedical - Devices
-$0.02 today
- Market cap
- $507.94M
- Beta
- 0.73
- P/E (TTM)
- -2.3
- EPS (TTM)
- -$4.04
Volume 1.24M
Average 1.18M
AVR EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Anteris Technologies Global Corp.NASDAQ: AVR
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA remains negative
Q1 FY2026 EBITDA was -$21.95M, compared with -$21.5M a year earlier. Trailing-twelve-month EBITDA was -$92.94M.
Context
- EBITDA amounted to 4834.9% of revenue in FY2025, up 2083.2 pp from a year earlier.
- EBITDA grew in size in 3 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of -$38.78M (+58.1%) for the fiscal year ending Dec 2026, a step up from the -24.4% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$21.95M+23.2% QoQ
- Last fiscal yearDec 2025
- -$92.49M-24.4% YoY
- LTMMar 2026
- -$92.94M-14.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -2.1% | +4.3% | +6.4 pp |
| 1 year | -24.4% | +58.1% | +82.4 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (92.49M) USD
- Year-over-year change
- -24.4%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (92.49M) | -24.4% |
| FY2024 | 2024-12-31 | (74.38M) | -63.3% |
| FY2023 | 2023-12-31 | (45.54M) | -56.3% |
| FY2022 | 2022-12-31 | (29.14M) | -88.0% |
| FY2021 | 2021-12-31 | (15.5M) | — |
EBITDA vs competitors
How AVR compares with its peers on the latest reported figures
- AVR's LTM Mar 2026 EBITDA of -$92.94M is the lowest of the 6 companies compared; the peer median is $1.58B.
- Its year-over-year change of -14.3% is the lowest of 6, against a peer median of +23.2%.
- EBITDA amounts to 5021.0% of revenue for AVR, versus a peer median of 24.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $10.27B | +9.8% | +4.1% | 27.3% | |
| LTM Jun 2026 | $5.8B | +23.2% | +23.0% | 27.6% | |
| LTM Jun 2026 | $1.58B | -11.2% | -9.6% | 24.3% | |
| LTM Sep 2026 | $211.36M | +363.4% | — | 14.0% | |
| LTM Mar 2026 | $65.05M | +84.5% | +35.4% | 14.2% | |
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | -$92.94M | -14.3% | — | 5021.0% |
| Peer median (excluding AVR) | $1.58B | +23.2% | +13.6% | 24.3% | |
Competitors are the stored peer set for AVR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 5.83M | 3.2M | 2.73M | 2.7M | 1.91M |
| Cost of Revenue | 3.93M | 2.9M | 1.86M | 1.44M | 2.23M |
| Gross Profit | 1.91M | 298.38K | 876.8K | 1.27M | (317K) |
| Gross Margin | 32.7% | 9.3% | 32.1% | 46.8% | -16.6% |
| Research & Development | 9.99M | 17.59M | 31.02M | 51.45M | 69.12M |
| Selling, General & Admin | 9.14M | 15.21M | 17.05M | 0 | 24.46M |
| Operating Expenses | 18.77M | 31.41M | 49.02M | 79.64M | 93.58M |
| Depreciation & Amortization | 640.09K | 774.08K | 1.16M | 1.51M | 1.66M |
| EBITDA | (15.5M) | (29.14M) | (45.54M) | (74.38M) | (92.49M) |
| EBITDA Margin | -265.8% | -910.5% | -1665.1% | -2751.7% | -4834.9% |
| Operating Income | (16.86M) | (31.11M) | (48.14M) | (78.37M) | (93.89M) |
| Operating Margin | -289.2% | -972.1% | -1760.3% | -2899.4% | -4908.2% |
| Interest Income | 68.55K | 210.38K | 428.06K | 0 | 709K |
| Interest Expense | 1.03M | 648.71K | 67.09K | 82K | 73K |
| Other Income / Expenses | (310.48K) | 550.48K | 1.38M | 2.41M | (331K) |
| Income Before Tax | (17.17M) | (30.56M) | (46.76M) | (75.97M) | (94.23M) |
| Pre-Tax Margin | -294.5% | -954.9% | -1709.9% | -2810.5% | -4925.5% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (17.17M) | (30.56M) | (46.02M) | (76.29M) | (94.14M) |
| Net Margin | -294.5% | -954.9% | -1682.8% | -2822.5% | -4921.3% |
| EPS (Basic) | (0.48) | (0.85) | (1.28) | (3.77) | (4.00) |
| EPS (Diluted) | (0.48) | (0.85) | (1.28) | (3.77) | (4.00) |
| Weighted Avg Shares | 35.94M | 35.94M | 35.94M | 20.25M | 23.58M |
| Weighted Avg Shares (Diluted) | 35.94M | 35.94M | 35.94M | 20.25M | 23.58M |
Anteris Technologies Global Corp.
NASDAQ:AVR
Intrinsic Alpha fair value
Locked
Current Price
$5.21
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.